Table 1.
Long-term survival of cases with synchronous Virchow lymph node metastasis of colorectal cancer
|
No.
|
Ref.
|
Year
|
Age/gender
|
Primary location
|
Metastasis of another organ
|
Resection of Virchow LN
|
Postoperative chemotherapy
|
Disease free survival time
|
Overall survival time
|
| 1 | Watanabe et al[3] | 2009 | 73/Male | Cecum | Paraaortic lymph nodes; Lung | - | 5-fluorouracil, Leucovorin, FOLFOX, FOLFIRI | - | 3 yr |
| 2 | Hirose et al[4] | 2010 | 57/Male | Rectum | - | - | FOLFOX, FOLFIRI | - | 3 yr |
| 3 | Ando et al[5] | 2013 | 63/Male | Sigmoid colon | - | - | FOLFOX, FOLFIRI | - | 5 yr |
| 4 | Suliman et al[6] | 2019 | 54/Male | Transverse colon | - | + | FOLFOX, FOLFIRI | - | - |
| 5 | Our case | 2020 | 56/Male | Sigmoid colon | - | + | FOLFOX, capecitabine, cetuximab | So far | So far |
FOLFOX: Fluorouracil, leucovorin and oxaliplatin; FOLFIRI: Fluorouracil, leucovorin and irinotecan; LN: Lymph node.